The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.
Nanotechnology for protein delivery: Overview and perspectives
Open accessAbstract
Protein-based therapeutics have made a significant impact in the treatment of a variety of important human diseases. However, given their intrinsically vulnerable structure and susceptibility to enzymatic degradation, many therapeutic proteins such as enzymes, growth factors, hormones, and cytokines suffer from poor physicochemical/biological stability and immunogenicity that may limit their potential benefits, and in some cases limit their utility. Furthermore, when protein therapeutics are developed for intracellular targets, their internalization and biological activity may be limited by inefficient membrane permeability and/or endosomal escape. Development of effective protein delivery strategies is therefore essential to further enhance therapeutic outcomes to enable widespread medical applications. This review discusses the advantages and limitations of marketed and developmental-stage protein delivery strategies, and provides a focused overview of recent advances in nanotechnology platforms for the systemic delivery of therapeutic proteins. In addition, we also highlight nanoparticle-mediated non-invasive administration approaches (e.g., oral, nasal, pulmonary, and transdermal routes) for protein delivery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Delivery of proteins such as catalase raises a few concerns such as its instability in vivo due to the presence of numerous physiological proteases, unpredictable protein immunogenicity, and poor in vivo half-life.27,28”
From Catalase-Integrated Hyaluronic Acid as Nanocarriers for Enhanced Photodynamic Therapy in Solid Tumor (2019) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Self-citationPushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,975
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
Prausnitz, M. R., & Langer, R. (2008) · Nature Biotechnology · doi:10.1038/nbt.1504 · Cited by 3,691
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V. S., Torchilin, V. P., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,951
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,925
Self-citationGold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity
Boisselier, É., & Astruc, D. (2009) · Chemical Society Reviews · doi:10.1039/b806051g · Cited by 2,832
Nanoparticles in Medicine: Therapeutic Applications and Developments
Zhang, L., Gu, F., Chan, J. M., Wang, A. Z., Langer, R., & Farokhzad, O. C. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100400 · Cited by 2,685
Self-citationPolymeric systems for controlled drug release
Uhrich, K. E., Cannizzaro, S. M., Langer, R. S., & Shakesheff, K. M. (1999) · Chemical Reviews · doi:10.1021/cr940351u · Cited by 2,633
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–407 of 407
Self-assembled protein–aptamer nanoparticles for targeted cancer immunotherapy
Wang, X., Li, S., Wang, T., Yang, Z., 王趁红, Chen, S., Cheng, H., Wang, Q., Gao, T., Lu, S., et al. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.154007
Spatiotemporal precision in gene editing: Stimulus-responsive delivery of CRISPR-Cas RNPs
Murthy, M. K. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108832
Nanotherapeutics in the treatment of cancer: transforming cancer care
Rad, M. K., Razani, E., & Bashash, D. (2026) · European Journal of Cancer Care · doi:10.48130/ejcc-0026-0007
Motahari, S., & Malayeri, M. R. (2026) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2026.129926
Zhao, X., Hu, K., Qin, Z., Lu, Y., Dai, Y., He, R., Du, P., Zhang, Y., Bai, L., Lv, Y., et al. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124637
Small phytopeptides: rising stars in broad-spectrum plant defense and sustainable crop protection
Shi, H., & Cheng, X. (2026) · The Crop Journal · doi:10.1016/j.cj.2026.09.010
Refaye, M. S. E., Challan, S. B., Ramadan, H. E., & Khater, S. I. (2026) · Discover Nano · doi:10.1186/s11671-026-04930-x
Metadata
- Authors
- Yu, M., Wu, J., Shi, J., & Farokhzad, O. C.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Shi, Jinjun
- Farokhzad, Omid C.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2016-10
- Volume
- 240
- Pages
- 24-37
- ISSN
- 0168-3659 (ISSN-L)
- PMC
- PMC4833694
- OpenAlex
- W2173147935
- Cited by
- 410
- References
- 138
- Citations by year
- 2026: 29 · 2025: 47 · 2024: 34 · 2023: 40 · 2022: 44 · 2021: 65 · 2020: 47 · 2019: 48 · 2018: 26 · 2017: 21 · 2016: 9
- FWCI
- 1.13
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Controlled Release (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Rare & Special e-Zone (The Hong Kong University of Science and Technology) (submittedVersion)
- Funders
- National Institutes of Health (NIH) (EB015419, R00CA160350, U54-CA151884)
- Movember-Prostate Cancer Foundation (PCF)
- National Research Foundation of Korea (K1A1A2048701)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- protein delivery, nanotechnology, therapeutic proteins, nanoparticle drug delivery, systemic drug delivery, intracellular delivery, endosomal escape, membrane permeability, protein stability, immunogenicity, oral drug delivery, intranasal drug delivery, pulmonary drug delivery, transdermal drug delivery
- MeSH terms
- Animals, Humans, Proteins, Tissue Distribution, Drug Delivery Systems, Nanotechnology, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
